Search
Now showing items 11-15 of 15
Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure
(SPRINGER, 2009)
Severe heart failure represents a major source of morbidity and mortality. Poor right ventricular function is an independent prognostic marker for mortality in patients with chronic heart failure. In this study, levosimendan ...
Levosimendan improves renal function in patients with acute decompensated heart failure: Comparison with dobutamine
(SPRINGER, 2007)
Background Levosimendan is a relatively new cardiac inotropic agent with calcium sensitizing activity. This study was conducted to investigate the effects of levosimendan (L) and dobutamine (D) on renal function in patients ...
Crimean-Congo hemorrhagic fever: does it involve the heart?
(ELSEVIER SCI LTD, 2009)
Objective: Crimean-Congo hemorrhagic fever (CCHF) is an acute viral hemorrhagic fever with a high mortality rate. Despite increasing knowledge about viral hemorrhagic fevers, the pathogenesis of CCHF and causes of death ...
Metabolic syndrome increases the risk of significant coronary artery involvement in patients with peripheral artery disease
(LIPPINCOTT WILLIAMS & WILKINS, 2006)
Background Peripheral artery disease is a common condition, mainly associated with clinical cardiovascular risk factors. Patients with peripheral artery disease suffer from coronary artery disease-related complications. ...
Comparison of myocardial performance index versus ratio of isovolumic contraction time/ejection time in left ventricular systolic dysfunction
(SPRINGER, 2007)
Myocardial performance index (MPI) has been regarded as an important parameter in the evaluation of ventricular systolic function in congestive heart failure. This study was designed to investigate the relationship between ...